Delivery Order SPE2DB20D3101-SPE2DB25FRUK2
- Not listed
- The Defense Logistics Agency awarded a $5,245.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count package) on August 21, 2025, with completion expected by August 22, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $9,071.48 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count package) on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99...
- The Defense Logistics Agency awarded a $34,561.46 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for...
- The Defense Logistics Agency awarded a delivery order valued at $16,979.99 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 27, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order represents a non-competitive award under the contractor's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,999.35 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,555.23 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,696.62 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $49,744.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $33,478.48 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, designated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,304.62 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The place...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUK2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $37,329.50 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on September 4, 2025, with completion targeted for September 5, 2025. This non-competed, firm fixed-price delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company was selected competitively for the underlying IDC and regularly fulfills delivery orders on behalf of the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for NURTEC ODT, a migraine treatment medication, reflects the company's role in supplying specialized pharmaceutical products to support military medical operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.3k | 9/4/25 |